Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis
Abstract Polypharmacy (PP) occurs in patients with type 2 diabetes (T2DM) owing to multimorbidity. We evaluated concomitant PP and medication adherence in T2DM 3 years after initiation of administration of a hypoglycaemic agent using a nationwide claim-based database in Japan. Factors associated wit...
Guardado en:
Autores principales: | Takeshi Horii, Makiko Iwasawa, Yusuke Kabeya, Koichiro Atuda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2430781ac5ab4bb1b22e866739c4b721 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021) -
Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: BMY Cheung, et al.
Publicado: (2020) -
Cost-Effectiveness of Oral Antidiabetic Drugs: A Prospective Multicenter Study of Real-World Patients
por: Gordon Liu, et al.
Publicado: (2021) -
Polypharmacy: Misleading, but manageable
por: Reamer L Bushardt, et al.
Publicado: (2008) -
Efficacy and safety of oral antidiabetic drugs in comparison to insulin in treating gestational diabetes mellitus: a meta-analysis.
por: Nalinee Poolsup, et al.
Publicado: (2014)